Sangamo Therapeutics Inc is a genomic medicine company committed to translating ground-breaking science into medicines that transform the lives of patients and families afflicted with serious neurological diseases.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Dr. Alexander Donald Macrae, M.B.,PhD$108.6M
Market Cap • 09/05/20241995
(há 29 anos)
2000
(24 years ago)
NASDAQ
Listagem
Richmond
Sede • California478
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
SGMOSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.